OLD Category: immuno-oncology

Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer

• Nam GH, Kwon M, Jung H...Roberts TM, Cho YB, Kim IS

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer

• Poma AM, Bruno R, Pietrini I, Alì G, Pasquini G, Proietti A, Vasile E, Cappelli S, Chella A, Fontanini G

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

• Nowicka M, Hilton LK, Ashton-Key M...Oestergaard MZ, Morin RD, Cragg MS

A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma

• Heong V, Tan TZ, Miwa M...Hasegawa K, Tan DS, Huang RY

Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

• Proctor M, Gonzalez Cruz JL, Daignault-Mill SM...Haass NK, Wells JW, Gabrielli B

Analysis of the Relationship between the Expression Levels of Neutrophil Gelatinase-Associated Lipocalin and Cytokine Genes in Bone Marrow

• Mun S, Park MC, Cho CH

Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients

• Eckstein M, Lieb V, Jung R...Wullich B, Taubert H, Wach S

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy

• Li R, He Y, Zhang H, Wang J, Liu X, Liu H, Wu H, Liang Z

Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas

• Angerilli V, Fontana E, Lonardi S...Loupakis F, Valeri N, Fassan M

The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade

• Hildebrand KM, Singla AK, McNeil R...Mahoney DJ, Jirik FR, Monument MJ

Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing

• Wolfson B, Padget MR, Schlom J, Hodge JW

Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients treated with immune checkpoint inhibitors

• Kim H, Kwon HJ, Kim ES, Kwon S, Suh KJ, Kim SH, Kim YJ, Lee JS, Chung JH